Halozyme Therapeutics, Inc. company logo
Halozyme Therapeutics, Inc. logo

Halozyme Therapeutics, Inc. (HALO) EBITDA

Annual EBITDA

$904.34M$271.56M+42.91%

Summary

Current Value
As of today, HALO annual EBITDA is $904.34M, up +42.91% on
Historical Performance
HALO annual EBITDA is up +166.71% over the past 3 years, up +512.95% over the past 5 years
All-Time High Comparison
HALO annual EBITDA is currently at its all-time high
3-Year Low Comparison
HALO annual EBITDA is +166.71% above its 3-year low of $339.07M reached on an earlier date
Sector Comparison
HALO annual EBITDA is higher than 92.72% of companies in Healthcare sector

EBITDA Chart

SUGGESTED SERIES

Performance

HALO Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$904.34M+42.9%+166.7%+513.0%+1886.2%
Quarterly EBITDA$321.67M+44.3%+179.5%+242.8%+9408.6%
TTM EBITDA$1.06B+38.6%+175.0%+300.0%+3268.1%
Price$103.12+66.0%+145.5%+154.6%+1576.8%
PE Ratio30.81+117.1%+25.1%+19.1%
Annual Revenue$1.40B+37.5%+111.6%+421.9%+10000.0%
Annual EPS$2.56-25.5%+77.9%+180.3%+556.7%
$816.29M+48.0%+182.0%+465.9%+1665.7%
Annual Net Income$316.89M-28.6%+56.8%+145.5%+695.2%

EBITDA Highs

HALO Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$904.34Mat high
5Y$904.34Mat high
All$904.34Mat high

EBITDA Lows

HALO Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y$339.07MN/A+166.7%
5Y$147.54MN/A+513.0%
All-$111.14M+913.7%

EBITDA History

YearValueChange
$904.34M+42.9%
$632.79M+49.8%
$422.43M+24.6%
$339.07M+21.6%
$278.90M+89.0%
$147.54M+552.8%
-$32.58M+70.7%
-$111.14M-233.6%
$83.16M+202.9%
-$80.80M-213.5%
-$25.78M+57.0%
-$59.87M+24.4%
-$79.21M-50.7%
YearValueChange
-$52.55M-180.3%
-$18.74M+63.0%
-$50.63M+9.9%
-$56.17M-15.2%
-$48.75M-76.8%
-$27.57M-79.8%
-$15.34M-14.9%
-$13.36M-47.0%
-$9.09M>-9,900.0%
-$79.10K-100.8%
-$39.40K+0.8%
-$39.70K-

FAQ

What is the current annual EBITDA of HALO?
As of today, HALO annual EBITDA is $904.34M
What is 1-year change in HALO annual EBITDA?
HALO annual EBITDA is up +42.91% year-over-year
What is 3-year change in HALO annual EBITDA?
HALO annual EBITDA is up +166.71% over the past 3 years
How far is HALO annual EBITDA from its all-time high?
HALO annual EBITDA is currently at its all-time high
How does HALO annual EBITDA rank versus sector peers?
HALO annual EBITDA is higher than 92.72% of companies in Healthcare sector
When is HALO next annual earnings release?
As of today, the next annual earnings release for HALO has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

  1. HALO Official Website halozyme.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1159036/000115903626000024/0001159036-26-000024-index.htm
  3. HALO Profile on Yahoo Finance finance.yahoo.com/quote/HALO
  4. HALO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/halo